Trial Profile
Effect of Lenalidomide on T-regulatory cells in patients with Multiple Myeloma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Sep 2016
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary) ; Bortezomib; Dexamethasone
- Indications Multiple myeloma
- Focus Therapeutic Use
- 16 Sep 2016 New trial record